Health Care Providers & Services · NYSE
DGXQuest Diagnostics Inc
- Last close
- $259.60 -0.0%
- 52-week range
- $171.18 to $262.00
- Market cap
- $28.6B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own 10 years
Above its 10-year median on all 4 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 25.9x
- Earnings yield
- 3.9%
- Price / sales
- 2.4x
- Price / book
- 3.7x
- Price / operating cash flow
- 14.6x
- EV / EBITDA
- 14.4x
- EV / sales
- 2.8x
- Free cash flow yield
- 4.8%
Profitability
- Gross margin
- 33.1%
- Operating margin
- 14.6%
- Net margin
- 9.5%
- Return on equity
- 14.8%
- Return on capital
- 10.1%
Growth per year
- Revenue, 3 years
- +3.7%
- Revenue, 5 years
- +3.2%
- Revenue, 9 years
- +4.8%
- EPS, 3 years
- +3.2%
Balance sheet
- Cash and investments
- $797M
- Total debt
- $5.55B
- Net cash
- -$4.75B
- Debt / equity
- 0.73x
- Current ratio
- 1.70x
Shares and dividend
- Shares outstanding
- 110M
- Share count, 5 years
- -16.9%
- Beta, 1 year
- -0.06
- Dividend yield
- 1.3%
- Dividend per share, TTM
- $3.38
- Payout ratio
- 32.7%
Ten years of the business
Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2016 to 2025.
Where the revenue comes from
All Other Segments went from 3% to 2% of revenue in 3 years
Share of revenue by business segment, fiscal 2022 to 2025, as reported in the 10-K.
| Business segment | Revenue | Share | vs FY24 |
|---|---|---|---|
| Diagnostic Information Services Business | $10.8B | 97.7% | +12% |
| All Other Segments | $250M | 2.3% | -3% |
Health Care Providers & Services peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| UNH Unitedhealth Group Inc | $365B | +3% | 5.3% | 23.3x | 0.8x | 68th percentile |
| MCK Mckesson Corp | $127B | +8% | 1.6% | 28.4x | 0.3x | 78th percentile |
| CVS CVS HEALTH Corp | $114B | +7% | 3.6% | 10.4x | 0.3x | 10th percentile |
| HCA HCA Healthcare, Inc. | $104B | +6% | n/a | 16.5x | 1.3x | 95th percentile |
| ELV Elevance Health, Inc. | $92.8B | +4% | 2.7% | 18.3x | 0.5x | 70th percentile |
| DGX Quest Diagnostics Inc | $28.6B | +9% | 14.5% | 25.9x | 2.4x | Highest in its range |
The company
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- CEO
- Steve Rusckowski
- Founded
- 1967
- Headquarters
- Secaucus, NJ
- Fiscal year ends
- December
- Website
- questdiagnostics.com
What it does
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about DGX.
Held by 815 active funds. Crowd level: crowd building, 10 rising quarters.
Open the Smart money tab